Buy ICICI Bank Ltd for the Target Rs 1,900 by Prabhudas Liladhar Ltd

ICICI Bank Ltd reported a strong quarter with a 3.7% beat on core PPoP, driven by loan growth of 7.3% QoQ. NIM declined 10bps QoQ to 4.28% due to FCNR impact but is expected to improve from Q4FY27. Prabhudas Liladhar raised its target price to INR 1,900 and reiterated a 'BUY' rating. Loan growth was led by corporate and SME sectors, while FCNR deposits increased significantly. Core PAT was 9.9% above estimates at INR146.5bn.

Original reporting
Published Oct 20, 2026, 7:05 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 8:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Buy ICICI Bank Ltd for the Target Rs 1,900 by Prabhudas Liladhar Ltd — source image
Decision brief

The 30-second read

Med
01

Why it matters

The earnings beat and raised target price suggest upside, but margin pressure may limit gains.

02

Market read

The earnings release provides fresh data for traders with exposure to Indian banking stocks.

03

What to watch

Potential impact of upcoming rate hikes on loan margins and the leveraged FCNR deposits.

Relevance 8/10Novelty 8/10Timing: post-market

Background

ICICI Bank reported a quarter with revenue and profit beats, higher loan growth, and a modest NIM dip due to FCNR funding.

Market effects

Strong loan growth and NIM trends may influence the Indian banking sector outlook.

Results could affect sentiment on Indian equities and RBI policy expectations.

Limited, primarily relevant to investors focused on emerging market financials.

Counterpoint

Despite earnings beat, NIM compression and FCNR funding risks could pressure the stock.

Key entities

  • ICICI Bank Ltd

    Indian bank that posted the earnings results.

Related articles

MedAI 8/10

ICICI Bank Q2 net profit rises 20.1% to INR 14,843 crore, asset quality improves

ICICI Bank reported a 20.1% year-on-year increase in standalone net profit to INR 14,843 crore for Q2 FY2026-27. Consolidated net profit rose 22.28% to INR 16,333.18 crore. Net interest income increased 17.7% to INR 25,339 crore, but net interest margin contracted by 0.12 percentage points to 4.18%. The bank's gross NPA ratio improved to 1.20%, and capital adequacy ratio rose to 16.68% as of September 30, 2026.

$IBNMedAI 8/10

How ICICI Bank Is Driving Loan Growth and Managing Risk?

ICICI Bank reported Q2 FY27 results with net interest income up 17.6% YoY and 4% QoQ, and net profit up 21% YoY and 6.8% QoQ. Loans grew 30% YoY, deposits rose 27.1% YoY, and bad loans declined. The bank's shares trade at a 6.4% discount to their 52-week high, with a P/E of 16.8.

HighAI 8/10

Buy ICICI Bank Ltd for the Target Rs.1,750 by Motilal Oswal Financial Services Ltd

ICICI Bank (ICICIBC) reported 2QFY27 PAT of INR148.4b, in line with expectations, driven by strong loan growth and controlled provisions. NIMs declined 18bp QoQ to 4.18%, but are expected to improve from 4QFY27. The bank raised its earnings estimate for FY28, with a target price of INR1,750. ICICIBC maintains strong asset quality and robust business growth, according to Motilal Oswal.

$IBNHighAI 8/10

Icici Bank Earnings Call Shows Robust Growth, Mild Strains

ICICI Bank reported Q2 earnings, showing strong profit growth (20.1% YoY), deposit (27.1% YoY), and loan (30% YoY) expansion. Asset quality improved, with net NPA ratio at 0.30%. Management noted near-term margin pressures but expressed confidence in long-term growth. Key growth areas included business banking, corporate lending, and jewel loans, while credit cards and corporate NPAs showed some stress.

$IBNHighAI 8/10

Buy ICICI Bank; target of Rs 1785: Emkay Global Financial

ICICI Bank reported a profit after tax of Rs148bn, 10% above estimates. Margins declined due to foreign currency non-resident deposits, but asset quality improved. Emkay Global raised loan growth forecasts to 30% for FY27 and increased earnings estimates. The bank's target price is set at Rs1785.